Benefits
The R&D tax credit is primarily a wage-based federal credit, which is worth up to 10% of qualified research expenses. Thus, a taxpayer with $1M of qualified wages could receive a benefit of up to $100,000. Many states also offer R&D tax credit that can greatly enhance the value of the study. Further, the credit can often be claimed for prior tax years.
The types of businesses that can benefit from an R&D study is far more expansive than what most people expect. Many of these industries have claimed the credit: Aerospace & Defense, Electronics, Architecture & Engineering, Food Science, Agriculture, Manufacturing, Automotive, Pharmaceuticals, Biotechnology & Bioengineering, Software Development, Chemicals, Telecommunications, and many more.
When the R&D credit was made permanent, it was expanded to allow a larger number of taxpayers that have been unable to take advantage of the credit previously.
- Small businesses can now take the R&D tax credit against their alternative minimum tax (AMT). The previous AMT restriction prevented qualified companies from utilizing the research credit, but new changes removed that hurdle for any qualified company with less than $50 million in gross receipts.
- Startup businesses with gross receipts of less than $5 million can now take the R&D tax credit against their payroll taxes (essentially making it a refundable credit for up to five years).
- Retroactive application: Qualified small businesses (average annual gross receipts of $31 million or less) could elect to apply these changes retroactively to 2022-2024 by amending those returns. Under IRS Rev. Proc. 2025-28, that election had to be made by July 6, 2026. Any business can still elect to deduct its remaining unamortized 2022-2024 U.S. research costs in its first tax year beginning after 2024, or split them over that year and the next.